✦ LIBER ✦

Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial

✍ Scribed by J.E. Tcheng; D.E. Kandzari; C.L. Grines

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gender Differences in Outcomes After Pri

✍ A.J. Lansky; C. Piedras; R.A. Costa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Cost-effectiveness of coronary stenting

✍ A. Bakhai; G.W. Stone; C.L. Grines 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Impact of anemia in patients with acute

✍ E. Nikolsky; E.D. Aymong; A. Halkin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Impact of stenting and abciximab in pati

✍ Thomas D. Stuckey; Gregg W. Stone; David A. Cox; James E. Tcheng; Eulogio Garcia 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Predictors of and outcomes of early thro

✍ George Dangas; Eve D. Aymong; Roxana Mehran; James E. Tcheng; Cindy L. Grines; D 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Combined fibrinolysis using reduced-dose

✍ Aaron Wong; Koon-Hou Mak; Charles Chan; Tian-Hai Koh; Kean-Wah Lau; Tai-Tian Lim 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views